Cutler Group LLC / CA - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 129 filers reported holding NOVOCURE LTD in Q4 2017. The put-call ratio across all filers is 0.22 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1
-99.2%
2,400
-81.6%
0.00%
-100.0%
Q2 2023$123
-68.8%
13,035
-47.0%
0.02%
-58.5%
Q1 2023$394
+4.5%
24,585
+153.5%
0.04%
+32.3%
Q4 2022$377
-99.9%
9,700
+10.2%
0.03%
+47.6%
Q3 2022$314,000
-1.9%
8,800
+20.5%
0.02%
-4.5%
Q2 2022$320,000
-13.7%
7,300
-64.6%
0.02%
+15.8%
Q1 2022$371,000
-65.7%
20,600
+41.5%
0.02%
-58.7%
Q4 2021$1,082,000
+86.2%
14,560
+79.8%
0.05%
+76.9%
Q3 2021$581,000
+52.5%
8,100
+200.0%
0.03%
+44.4%
Q2 2021$381,000
+353.6%
2,700
+200.0%
0.02%
+350.0%
Q4 2020$84,000
+189.7%
9000.0%0.00%
+100.0%
Q3 2020$29,000
-6.5%
900
-35.7%
0.00%0.0%
Q2 2020$31,000
-68.7%
1,400
-37.8%
0.00%
-60.0%
Q1 2020$99,000
+8.8%
2,250
-64.8%
0.01%
-44.4%
Q3 2019$91,000
+145.9%
6,400
+6.7%
0.01%
+200.0%
Q2 2019$37,000
+19.4%
6,000
-50.4%
0.00%
+200.0%
Q4 2017$31,000
-73.3%
12,106
-36.5%
0.00%
-75.0%
Q3 2017$116,000
-56.9%
19,077
-73.8%
0.00%
-60.0%
Q2 2017$269,000
+767.7%
72,700
+251.2%
0.01%
+900.0%
Q1 2017$31,000
-27.9%
20,700
+145.7%
0.00%0.0%
Q4 2016$43,000
+53.6%
8,424
-81.7%
0.00%
-50.0%
Q3 2016$28,000
-60.6%
46,000
+122.2%
0.00%
-33.3%
Q2 2016$71,000
-40.8%
20,700
+72.5%
0.00%
-62.5%
Q1 2016$120,000
-36.5%
12,000
+5.9%
0.01%
-20.0%
Q4 2015$189,00011,3340.01%
Other shareholders
NOVOCURE LTD shareholders Q4 2017
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders